Coronary Artery Bypass Graft (CABG) Market Size, Share and Growth Outlook, 2026

Coronary Artery Bypass Graft (CABG) Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Coronary Artery Bypass Graft (CABG) Market size is forecast to increase from $25.75 Billion in 2026 to $34.97 Billion in 2034 at a CAGR of 3.9% between 2026 and 2034.

The Coronary Artery Bypass Graft (CABG) market report provides detailed analysis and outlook of Coronary Artery Bypass Graft (CABG) segments including By Technology (Off-Pump CABG, On-Pump CABG, Minimally Invasive Direct Coronary Artery Bypass, Robotic-Assisted CABG), By Procedure Type (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery), By Graft Type (Saphenous Vein Grafts, Internal Mammary Artery Grafts, Radial Artery Grafts), By End User (Hospitals, Cardiology Centers, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Coronary Artery Bypass Graft (CABG) Industry Overview

Minimally Invasive and Robotic Techniques Transforming CABG Procedures

The coronary artery bypass graft (CABG) industry continues to evolve through the adoption of less invasive surgical approaches designed to improve patient outcomes and reduce recovery times. Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) and robotic-assisted bypass procedures are gaining increasing attention across leading cardiovascular centers. Published clinical outcomes demonstrate that these advanced techniques can reduce postoperative complications, minimize surgical trauma, and accelerate patient recovery compared with traditional sternotomy-based CABG procedures. By utilizing smaller incisions and advanced robotic technologies, surgeons can perform highly precise grafting procedures while reducing hospital stays and improving postoperative quality of life. The growing adoption of minimally invasive cardiovascular surgery reflects broader healthcare trends focused on enhancing procedural efficiency, reducing patient morbidity, and improving long-term surgical outcomes.

Virtual Reality Training Enhancing Surgical Education and Standardization

Advances in medical education technologies are becoming increasingly important within the coronary artery bypass graft industry. Major university medical centers have begun implementing high-fidelity virtual reality training platforms to support the education of cardiothoracic surgery fellows and residents. These immersive simulation systems allow surgeons to practice complex bypass grafting procedures within realistic virtual environments before performing operations on patients. The adoption of VR-based surgical training reflects a broader effort to standardize procedural techniques, improve technical proficiency, and enhance patient safety. By enabling repeated practice of challenging surgical scenarios, virtual reality platforms support skill development while reducing variability in surgical performance. As simulation-based education becomes more sophisticated, it is playing an increasingly important role in preparing future cardiovascular surgeons for complex coronary revascularization procedures.

Advanced Imaging and Diagnostic Planning Improving Surgical Outcomes

The integration of advanced imaging technologies into preoperative planning is significantly influencing the coronary artery bypass graft industry. Updated clinical protocols increasingly incorporate automated coronary artery calcium scoring, three-dimensional computed tomography reconstructions, and other advanced diagnostic tools to improve patient assessment before surgery. These technologies allow clinicians to identify high-risk arterial anatomy, evaluate plaque burden, and assess vessel quality with greater precision. Enhanced visualization of coronary structures enables surgeons to develop more effective grafting strategies and optimize conduit selection before entering the operating room. Improved preoperative planning contributes to better graft placement, enhanced long-term graft patency, and reduced procedural risks. As cardiovascular imaging technologies continue to advance, their integration into CABG planning is supporting more personalized and data-driven surgical decision-making across modern cardiac care programs.

Coronary Artery Bypass Graft (CABG) Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Coronary Artery Bypass Graft (CABG) market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Medtronic plc, Terumo Corporation (Terumo Cardiovascular), Getinge AB, W. L. Gore & Associates, Inc., B. Braun SE, Abbott Laboratories, LivaNova plc, Edwards Lifesciences Corporation, Transonic Systems Inc., Vascular Graft Solutions Ltd.. The Coronary Artery Bypass Graft (CABG) market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Coronary Artery Bypass Graft (CABG) industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Coronary Artery Bypass Graft (CABG) Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Coronary Artery Bypass Graft (CABG) companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Coronary Artery Bypass Graft (CABG) markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Coronary Artery Bypass Graft (CABG) Market Competitive Benchmarking and Company Analysis

Leading companies in Coronary Artery Bypass Graft (CABG) industry include- Medtronic plc, Terumo Corporation (Terumo Cardiovascular), Getinge AB, W. L. Gore & Associates, Inc., B. Braun SE, Abbott Laboratories, LivaNova plc, Edwards Lifesciences Corporation, Transonic Systems Inc., Vascular Graft Solutions Ltd.. The Coronary Artery Bypass Graft (CABG) market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Coronary Artery Bypass Graft (CABG) Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Coronary Artery Bypass Graft (CABG) market remains one of the strongest-performing segments in the country.
The US Coronary Artery Bypass Graft (CABG) Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Coronary Artery Bypass Graft (CABG) market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Coronary Artery Bypass Graft (CABG) industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Coronary Artery Bypass Graft (CABG) markets

Canada's strong Coronary Artery Bypass Graft (CABG) sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Coronary Artery Bypass Graft (CABG) market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Coronary Artery Bypass Graft (CABG) Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Coronary Artery Bypass Graft (CABG) market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Coronary Artery Bypass Graft (CABG) population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Coronary Artery Bypass Graft (CABG) industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Coronary Artery Bypass Graft (CABG) market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Coronary Artery Bypass Graft (CABG) sales through 2034

France Coronary Artery Bypass Graft (CABG) companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Coronary Artery Bypass Graft (CABG) Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Coronary Artery Bypass Graft (CABG) distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Coronary Artery Bypass Graft (CABG) Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Coronary Artery Bypass Graft (CABG) market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Coronary Artery Bypass Graft (CABG) industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Coronary Artery Bypass Graft (CABG) industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Coronary Artery Bypass Graft (CABG) Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Coronary Artery Bypass Graft (CABG) market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Coronary Artery Bypass Graft (CABG) market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Coronary Artery Bypass Graft (CABG) Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Coronary Artery Bypass Graft (CABG) Market Segmentation

By Technology
Off-Pump CABG
On-Pump CABG
Minimally Invasive Direct Coronary Artery Bypass
Robotic-Assisted CABG
By Procedure Type
Single CABG Surgery
Double CABG Surgery
Triple CABG Surgery
Quadruple CABG Surgery
By Graft Type
Saphenous Vein Grafts
Internal Mammary Artery Grafts
Radial Artery Grafts
By End User
Hospitals
Cardiology Centers
Ambulatory Surgical Centers

Top Companies in Coronary Artery Bypass Graft (CABG) Industry

Medtronic plc
Terumo Corporation (Terumo Cardiovascular)
Getinge AB
W. L. Gore & Associates, Inc.
B. Braun SE
Abbott Laboratories
LivaNova plc
Edwards Lifesciences Corporation
Transonic Systems Inc.
Vascular Graft Solutions Ltd.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa